Peptide-Coupled Peripheral Blood Mononuclear Cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Peptide-Coupled Peripheral Blood Mononuclear Cells, covering 2015-04-08 to 2015-04-08. Get the full timeline:
Most recent: Clinical Trial Update: Establish Tolerance In MS With Peptide-Coupled, Peripheral Blood Mononuclear Cells [Phase 1, Phase 2]